Ep 59: Photon Health CEO Otto Sipe on the Future of Pharmacies, PBMs and GLP-1s

This episode explores the evolution and current state of e-prescribing and the broader pharmacy industry, featuring Otto Sipe, CEO of Photon Health. Against the backdrop of a near-monopoly in e-prescribing held by SureScripts, the discussion highlights Photon's innovative approach to reorienting the prescription around the patient, enabling them to choose their pharmacy based on factors like price, location, and availability. More significantly, Photon leverages AI-powered phone calls to gather real-time pharmacy information, enhancing patient experience and addressing limitations of existing one-way e-prescription networks. As the discussion pivoted to the pharmacy industry's inefficiencies, Sipe argued that the market lags behind e-commerce trends due to complexities in benefits design. For instance, he compared the current system to buying milk with convoluted pricing and transfer processes. In contrast to previous attempts at pharmacy innovation, Photon focuses on creating value at the infrastructure level, addressing challenges posed by Pharmacy Benefit Managers (PBMs). The conversation concludes with Sipe's vision for a future where AI streamlines processes, marketplaces govern drug pricing, and pharmacists play a more significant role in patient care, potentially leading to outcome-based pricing models. This reflects emerging industry patterns toward greater transparency, patient empowerment, and the potential disruption of traditional PBM models.